What is an expected therapeutic effect of misoprostol (Cytotec) in a client who chronically uses NSAIDs?

The correct choice focuses on the expected therapeutic effect of misoprostol, particularly in patients who chronically use nonsteroidal anti-inflammatory drugs (NSAIDs). Misoprostol acts as a prostaglandin analogue and is primarily indicated for the prevention of NSAID-induced gastric ulcers. By enhancing the production of mucus and bicarbonate in the stomach, misoprostol protects the gastric lining and promotes healing, resulting in relief from epigastric pain associated with gastric irritation or ulceration.

In patients who take NSAIDs regularly, there is an increased risk of gastrointestinal side effects, including irritation and ulceration of the gastric mucosa. Therefore, the ability of misoprostol to reduce gastric discomfort and associated pain directly relates to its therapeutic purpose, making relief of epigastric pain a primary expected outcome of its use.

Other options, while they may seem relevant in different contexts, do not align with the specific therapeutic goals of misoprostol in this scenario. For example, resolved diarrhea may occur as a side effect rather than a therapeutic goal, and decreased platelet or white blood cell counts are not direct effects relevant to misoprostol's treatment for NSAID-related issues. Thus, understanding misoprostol’s protective